Our Leadership Team

Our Board of Directors, Leadership Team and Scientific & Medical Advisory Board ensure that we have the depth of expertise and experience to accelerate the world’s transition to gene-based personalised, preventive healthcare.

Meet our Board of Directors

Mr. Peter Rubinstein

Mr. Peter Rubinstein

Chairman & Non – Executive Director

Dr. Lindsay Wakefield

Dr. Lindsay Wakefield

Non – Executive Director

Mr. Nick Burrows

Mr. Nick Burrows

Non – Executive Director

Dr. Jerzy “George” Muchnicki

Dr. Jerzy “George” Muchnicki

Non-Executive Director

Meet our Senior Management Team

Simon Morriss

Simon Morriss

Chief Executive Officer

Mike Tonroe

Mike Tonroe

Chief Financial Officer

Dr. Richard Allman

Dr. Richard Allman

Chief Scientific Officer

Dr. Erika Spaeth

Dr. Erika Spaeth

Director of Clinical Affairs & Medical Education

Dr. Jerzy “George” Muchnicki

Dr. Jerzy “George” Muchnicki

Medical Advisor

Carl Stubbings

Carl Stubbings

Chief Commercial Officer

Meet our Scientific & Medical
Advisory Board

Dr. Ora K. Gordon, M.D.

Dr. Ora K. Gordon, M.D.

MD, MS, FACMG

Regional Medical Director, Center for Clinical Genetics & Genomics. Clinical Director, PSJH Population Health Genomics Program. Chair, Integrated Network Cancer Program, Professor of Genetics, St John Cancer Institute

Professor Jon Emery

Professor Jon Emery

MBBCh MA DPhil FRACGP MRCGP

Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne

Professor Finlay Macrae AO

Professor Finlay Macrae AO

MBBS, MD, FRACP, FRCP, AGAF MWGO

Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital

Connect with us

GeneType is committed to increasing awareness of preventative, personalised healthcare. If you would like to work with us to raise the profile of personalised medicine, our team of experts is ready to speak with you.